These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New trends on the pathogenetic aspects of allergic bronchial asthma. Ricci M; Del Prete GF; Maggi E; Romagnani S Respiration; 1986; 50 Suppl 2():103-15. PubMed ID: 2951791 [TBL] [Abstract][Full Text] [Related]
3. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma. Hesse L; Petersen AH; Nawijn MC Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of CD23-mediated IgE transcytosis suppresses the initiation and development of allergic airway inflammation. Palaniyandi S; Liu X; Periasamy S; Ma A; Tang J; Jenkins M; Tuo W; Song W; Keegan AD; Conrad DH; Zhu X Mucosal Immunol; 2015 Nov; 8(6):1262-74. PubMed ID: 25783969 [TBL] [Abstract][Full Text] [Related]
5. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma. Hesse L; Nawijn MC Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043 [TBL] [Abstract][Full Text] [Related]
7. Allergen inhalation challenge: a human model of asthma exacerbation. Gauvreau GM; Evans MY Contrib Microbiol; 2007; 14():21-32. PubMed ID: 17684330 [TBL] [Abstract][Full Text] [Related]
8. Anti-IgE efficacy in murine asthma models is dependent on the method of allergen sensitization. Tumas DB; Chan B; Werther W; Wrin T; Vennari J; Desjardin N; Shields RL; Jardieu P J Allergy Clin Immunol; 2001 Jun; 107(6):1025-33. PubMed ID: 11398080 [TBL] [Abstract][Full Text] [Related]
9. Protective Role of Matrix Metalloproteinase-2 in Allergic Bronchial Asthma. Takahashi Y; Kobayashi T; D'Alessandro-Gabazza CN; Toda M; Fujiwara K; Okano T; Fujimoto H; Asayama K; Takeshita A; Yasuma T; Nishihama K; Inoue R; Qin L; Takei Y; Taguchi O; Gabazza EC Front Immunol; 2019; 10():1795. PubMed ID: 31428095 [TBL] [Abstract][Full Text] [Related]
10. Inducible costimulator-positive T cells are required for allergen-induced local B-cell infiltration and antigen-specific IgE production in lung tissue. Beier KC; Hutloff A; Löhning M; Kallinich T; Kroczek RA; Hamelmann E J Allergy Clin Immunol; 2004 Oct; 114(4):775-82. PubMed ID: 15480315 [TBL] [Abstract][Full Text] [Related]
11. Particulate allergens potentiate allergic asthma in mice through sustained IgE-mediated mast cell activation. Jin C; Shelburne CP; Li G; Potts EN; Riebe KJ; Sempowski GD; Foster WM; Abraham SN J Clin Invest; 2011 Mar; 121(3):941-55. PubMed ID: 21285515 [TBL] [Abstract][Full Text] [Related]
12. The role of IgE in asthma. Yssel H; Abbal C; Pène J; Bousquet J Clin Exp Allergy; 1998 Nov; 28 Suppl 5():104-9; discussion 117-8. PubMed ID: 9988455 [TBL] [Abstract][Full Text] [Related]
13. Sputum cytology during late-phase responses to inhalation challenge with different allergens. Revez JA; Killian KJ; O'Byrne PM; Boulet LP; Upham JW; Gauvreau GM; Ferreira MAR Allergy; 2018 Jul; 73(7):1470-1478. PubMed ID: 29337345 [TBL] [Abstract][Full Text] [Related]
15. Functional inhibition of PAR2 alleviates allergen-induced airway hyperresponsiveness and inflammation. Asaduzzaman M; Nadeem A; Arizmendi N; Davidson C; Nichols HL; Abel M; Ionescu LI; Puttagunta L; Thebaud B; Gordon J; DeFea K; Hollenberg MD; Vliagoftis H Clin Exp Allergy; 2015 Dec; 45(12):1844-55. PubMed ID: 26312432 [TBL] [Abstract][Full Text] [Related]
16. Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases. D'Amato G; Liccardi G; Noschese P; Salzillo A; D'Amato M; Cazzola M Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):227-9. PubMed ID: 15379589 [TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of a murine model for allergic asthma using allergen-specific IgE monoclonal antibody to study pathological roles of IgE. Mizutani N; Goshima H; Nabe T; Yoshino S Immunol Lett; 2012 Jan; 141(2):235-45. PubMed ID: 22037571 [TBL] [Abstract][Full Text] [Related]
18. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Mehlhop PD; van de Rijn M; Goldberg AB; Brewer JP; Kurup VP; Martin TR; Oettgen HC Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1344-9. PubMed ID: 9037055 [TBL] [Abstract][Full Text] [Related]
19. Th17 response to Dermatophagoides pteronyssinus is related to late-phase airway and systemic inflammation in allergic asthma. Bajoriuniene I; Malakauskas K; Lavinskiene S; Jeroch J; Sakalauskas R Int Immunopharmacol; 2013 Dec; 17(4):1020-7. PubMed ID: 24161744 [TBL] [Abstract][Full Text] [Related]
20. Increase in allergen-specific IgE and ex vivo Th2 responses after a single bronchial challenge with house dust mite in allergic asthmatics. van de Pol MA; Lutter R; van Ree R; van der Zee JS Allergy; 2012 Jan; 67(1):67-73. PubMed ID: 21958117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]